Skip Navigation

Europace 2003 5(s1):S42-S48; doi:10.1016/j.eupc.2004.07.001
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cazeau, S.
Right arrow Articles by Ritter, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cazeau, S.
Right arrow Articles by Ritter, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Cardiac resynchronization therapy

S. Cazeaua,b,*, C. Alonsoa,b, G. Jauverta,b, A. Lazarusa,b and P. Rittera,b

aInParys, Clinique Georges Bizet Paris, France; bInParys, Clinique du Val d'Or Saint-Cloud, France

The first case report introducing the concept of cardiac resynchronisation therapy (CRT) was published less than 10 years ago, opening the way to the development of the first successful non-pharmacological treatment of congestive heart failure (CHF). The now routine implantation of CRT systems is applicable to multitudes of patients as adjunctive therapy in advanced CHF. This technique has transformed the traditional concepts associated with stimulation of the heart, and is now applied not only to restore an appropriate heart rate, but also to change the process of cardiac mechanical activation. Since it must be integrated within a comprehensive and multidisciplinary CHF management program, CRT has changed the practice of experts in the field of cardiac pacing. CRT in the management of CHF was ultimately validated in 2 randomised trials. MUSTIC, the first trial, compared in a single-blind, 3 × 3 months crossover design active versus inactive biventricular stimulation in a group of patients in sinus rhythm and another group in atrial fibrillation. Both phases of the trial were completed by 48 patients, with significant positive effects conferred by CRT on the distance walked in 6 min and on peak oxygen consumption. The number of hospitalizations for management of CHF was decreased by 2/3 (P < 0.05), and 85% of patients preferred the atrio-biventricular over the inactive stimulation mode (P < 0.001). These results were amply confirmed by the parallel-design MIRACLE trial. The current indications for CRT, dignostic tools to assist in its implementation, and limitations of this new therapeutic adjunct are further discussed in this review.

Key Words: cardiac resynchronization therapy, multisite cardiac pacing, atrial fibrillation, heart failure

*Corresponding author. InParys, 12 rue Pasteur, 92210 Saint-Cloud, France. Tel.: +33 1 41 12 07 13. E-mail address: cazeau{at}inparys.com (S. Cazeau).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.